Your browser doesn't support javascript.
loading
Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials.
Sinicrope, Frank A; Chakrabarti, Sakti; Laurent-Puig, Pierre; Huebner, Luke; Smyrk, Thomas C; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M; Zaanan, Aziz; Folprecht, Gunnar; Van Laethem, Jean Luc; Le Malicot, Karine; Shi, Qian; Alberts, Steven R; Taieb, Julien.
Affiliation
  • Sinicrope FA; Department of Oncology, Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester, MN, USA. Electronic address: sinicrope.frank@mayo.edu.
  • Chakrabarti S; Department of Oncology, Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester, MN, USA.
  • Laurent-Puig P; Centre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, Paris, France.
  • Huebner L; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Smyrk TC; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), UVic, IOB-Quiron, Barcelona, Spain.
  • Mini E; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Goldberg RM; Department of Medicine, West Virginia University Cancer Center, Morgantown, WV, USA.
  • Zaanan A; Department of Gastroenterology and GI Oncology, Sorbonne Paris Cité, Université Paris Descartes, Hopital Européen Georges Pompidou, Paris, France.
  • Folprecht G; First Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Van Laethem JL; Department of Gastroenterology, Erasme Hospital University, Brussels, Belgium.
  • Le Malicot K; Department of Statistics, Fédération Francophone de Cancérologie Digestive, EPICAD INSERM, France.
  • Shi Q; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Alberts SR; Department of Oncology, Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester, MN, USA.
  • Taieb J; Department of Gastroenterology and GI Oncology, Sorbonne Paris Cité, Université Paris Descartes, Hopital Européen Georges Pompidou, Paris, France.
Eur J Cancer ; 144: 101-112, 2021 02.
Article in En | MEDLINE | ID: mdl-33341444

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Chemotherapy, Adjuvant / Colonic Neoplasms / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur J Cancer Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Chemotherapy, Adjuvant / Colonic Neoplasms / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur J Cancer Year: 2021 Type: Article